Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Bulgarian animal healthcare company Huvepharma has become the latest casualty in an IPO market oversaturated with supply. -
The EBRD’s central and eastern European heartland faces tough challenges as it seeks to regain its economic footing after being laid low by the outbreak of the Covid-19 pandemic
-
Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m).
-
South Korean pharmaceutical company HK Inno.N Corp has kicked off pre-deal investor education for its IPO, according to a source familiar with the matter.
-
The oil-rich nation took a blow from the global pandemic, but Kazakhstan is getting back on track
-
Kindstar Globalgene Technology and Dexin Services Group both rolled out their Hong Kong IPOs on Tuesday.
